BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38452707)

  • 1. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
    Agrawal T; Maddileti S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
    Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
    Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
    Deng X; Iwagawa T; Fukushima M; Watanabe S
    Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of two H1 hESC sublines carrying deletions of RB1 exon 1/promoter in heterozygous or compound heterozygous state.
    Menges J; Cremanns M; Steenpass L
    Stem Cell Res; 2019 Aug; 39():101517. PubMed ID: 31404748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
    Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
    Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
    Avior Y; Lezmi E; Yanuka D; Benvenisty N
    Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of RB1 in human embryonic stem cell-derived retinal organoids.
    Zheng C; Schneider JW; Hsieh J
    Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
    Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
    Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous RB1 mutation enhanced ATP production in human iPSC-derived retinal organoids.
    Vincent A; Krishnakumar S; Parameswaran S
    Mol Biol Rep; 2024 May; 51(1):606. PubMed ID: 38704498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational screening of germline
    Nguyen HH; Nguyen HTT; Vu NP; Le QT; Pham CM; Huyen TT; Manh H; Pham HLB; Nguyen TD; Le HTT; Van Nong H
    Mol Vis; 2018; 24():231-238. PubMed ID: 29568217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of two induced pluripotent stem cell lines from conjunctiva of a retinoblastoma patient.
    Xu P; Guo F; Xiao W; Wang Y; Ye K; Mao Y; Zhong X
    Stem Cell Res; 2023 Oct; 72():103200. PubMed ID: 37708614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of germline mutations in RB1 in Chinese patients with retinoblastoma: Application of targeted next-generation sequencing.
    Zou Y; Li J; Hua P; Liang T; Ji X; Zhao P
    Mol Vis; 2021; 27():1-16. PubMed ID: 33456302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of RB1 mutant and MYCN amplified retinoblastoma cell lines.
    Schwermer M; Hiber M; Dreesmann S; Rieb A; Theißen J; Herold T; Schramm A; Temming P; Steenpass L
    Exp Cell Res; 2019 Feb; 375(2):92-99. PubMed ID: 30584916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of mutations in the
    Kiet NC; Khuong LT; Minh DD; ; Quan NHM; Xinh PT; Trang NNC; Luan NT; Khai NM; Vu HA
    Mol Vis; 2019; 25():215-221. PubMed ID: 30996590
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Fang X; Chen J; Wang Y; Zhao M; Zhang X; Yang L; Ni X; Zhao J; Gallie BL
    Ophthalmic Genet; 2021 Oct; 42(5):593-599. PubMed ID: 34190019
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel insights into RB1 mutation.
    Yao Y; Gu X; Xu X; Ge S; Jia R
    Cancer Lett; 2022 Oct; 547():215870. PubMed ID: 35964818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
    Indovina P; Pentimalli F; Conti D; Giordano A
    Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular alterations in retinoblastoma beyond RB1.
    Mendonça V; Evangelista AC; P Matta B; M Moreira MÂ; Faria P; Lucena E; Seuánez HN
    Exp Eye Res; 2021 Oct; 211():108753. PubMed ID: 34478740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and germline mutation spectrum of RB1 in Chinese patients with retinoblastoma: A dual-center study of 145 patients.
    Chai P; Luo Y; Yu J; Li Y; Yang J; Zhuang A; Fan J; Han M; Jia R
    Exp Eye Res; 2021 Apr; 205():108456. PubMed ID: 33493472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.